|
Volumn 38, Issue 972, 1996, Pages 35-37
|
New drugs for HIV infection
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ASTEMIZOLE;
DIDANOSINE;
INDINAVIR;
LAMIVUDINE;
NEW DRUG;
NUCLEOSIDE DERIVATIVE;
PROTEINASE INHIBITOR;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
TERFENADINE;
ZALCITABINE;
ZIDOVUDINE;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
DEATH;
DRUG APPROVAL;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG INFORMATION;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEART ARRHYTHMIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NEUTROPENIA;
PANCREATITIS;
PERIPHERAL NEUROPATHY;
SENSORY NEUROPATHY;
SHORT SURVEY;
SIDE EFFECT;
ANTIVIRAL AGENTS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
INDINAVIR;
ISOQUINOLINES;
LAMIVUDINE;
PYRIDINES;
QUINOLINES;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
THIAZOLES;
VALINE;
ZALCITABINE;
|
EID: 0029932658
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (48)
|
References (0)
|